Sean Wharton

15.4k citations
94 papers · 8.3k indexed · 8 hit papers · h-index 28
Topics
Pharmacology and Obesity Treatment (50 papers)Diabetes Treatment and Management (48 papers)Metabolism, Diabetes, and Cancer (29 papers)

In The Last Decade

Sean Wharton

83 papers receiving 8.1k citations

Hit Papers

Once-Weekly Semaglutide in Adults with Overweight or O...20182026202020232021202220182022202250010001.5k2.0k

Peers

Sean Wharton
Comparison fields: 5 of 127
  • Endocrinology, Diabetes and Metabolism 4.8k
  • Pharmacology 3.5k
  • Physiology 2.6k
  • Surgery 2.0k
  • Molecular Biology 1.8k
Replace David C.W. Lau with:
David C.W. Lau Canada
Ildiko Lingvay United States
Juan P. Frías United States
Christopher D. Still United States
Vanita R. Aroda United States
Alfredo Halpern Brazil
Bernhard Ludvik Austria
Sue D. Pedersen Canada
Sangeeta R. Kashyap United States
Helena Hämäläinen Finland
Sean Wharton relative to David C.W. Lau Canada David C.W. Lau's profile →
Citations per field
00.5×5.1×
David C.W. Lau · 1×
Citations per year

Countries citing papers authored by Sean Wharton

Since Specialization
Citations

This map shows the geographic impact of Sean Wharton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean Wharton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean Wharton more than expected).

Fields of papers citing papers by Sean Wharton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean Wharton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean Wharton. The network helps show where Sean Wharton may publish in the future.

Co-authorship network of co-authors of Sean Wharton

This figure shows the co-authorship network connecting the top 25 collaborators of Sean Wharton. A scholar is included among the top collaborators of Sean Wharton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean Wharton. Sean Wharton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 10
5 14
6 0
7 3
8 5
9
Tirzepatide for Obesity Treatment and Diabetes Preventionbreakdown →
133
10 1
11 25
12 1
13 18
14 42
15
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trialbreakdown →
469
16 0
17 1
18 102
19 27
20 49

About Sean Wharton

Sean Wharton is a scholar working on Pharmacy, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 94 papers that have together received 8.3k indexed citations. Recurring topics across this work include Pharmacology and Obesity Treatment (50 papers), Diabetes Treatment and Management (48 papers) and Metabolism, Diabetes, and Cancer (29 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.8k citations), Pharmacology (3.5k citations) and Pharmacy (607 citations). Sean Wharton has collaborated with scholars based in Canada, United States and Denmark. Frequent co-authors include John Wilding, Thomas A. Wadden, Barbara McGowan, Rachel L. Batterham, Ildiko Lingvay, Melanie J. Davies, Julio Rosenstock, Robert F. Kushner, Luc F. Van Gaal and Koutaro Yokote. Their work appears in journals such as New England Journal of Medicine, The Lancet and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026